Table 1.
Demographic and clinical characteristics of the COVID-19 patient cohort.
| Characteristic | N. patients | Mean (Range or %) or N (%) | |
|---|---|---|---|
| Age | 660a | 70 (17–96) | |
| Gender | 662 | ||
| Male | 451 (68) | ||
| Female | 211 (32) | ||
| Ethnicity | 206 | ||
| Caucasian | 61 (30) | ||
| African American | 68 (33) | ||
| Asian | 5 (2) | ||
| Hispanic | 57 (28) | ||
| African | 1 (0) | ||
| Other | 6 (3) | ||
| Unknown | 8 (4) | ||
| Comorbidities | 525 | ||
| Hypertension | 299 (57) | ||
| Diabetes | 174 (33) | ||
| COPD/Asthma | 93 (18) | ||
| Obesity | 103 (20) | ||
| Congestive Heart Failure | 50 (9) | ||
| PAD/CVD/MI | 130 (25) | ||
| Cardiomyopathy | 23 (4) | ||
| Chronic Kidney Disease | 82 (16) | ||
| Liver disease/Cirrhosis | 16 (3) | ||
| Cerebrovascular disease | 15 (3) | ||
| Dementia/Alzheimer/Parkinson | 51 (10) | ||
| Cancer | 64 (12) | ||
| Transplant/Immunosuppression | 17 (3) | ||
aAge was not reported in 2 patients [42].